Novartis reported late-stage trial results for GanLum, a new malaria treatment that contains the molecule ganaplacide. Michael Delves of the London School of Hygiene and Tropical Medicine, who helped early development but was not involved in the trial, said the molecule is completely new and that Plasmodium has not seen it before and so has no defence.
The trial covered more than 1,600 patients across 12 countries in sub‑Saharan Africa. GanLum, given as a daily sachet of granules for three days, cured 97.4% of participants versus 94% for an existing treatment. The drug also targets the parasite as it prepares to transmit the disease to mosquitoes, which could reduce new cases and slow the spread of resistance.
Medicines for Malaria Venture, which co-developed the drug with Novartis, said regulatory approvals might take around 16 months and that the drug could reach the market in 2027. Researchers and public health experts welcomed the results.
Difficult words
- treatment — A way to help someone who is sick.treat, treatments
- promise — A belief that something will be successful.
- patient — A person receiving medical care.patients
- transmission — The act of passing something on.
- resistance — Ability to fight against something harmful.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What do you think about new malaria treatments?
- How important is it to prevent disease transmission?
- What challenges might GanLum face before it is approved?
Related articles
Jaw membrane in ancient Thrinaxodon may be an early eardrum
Researchers used CT scans and engineering simulations on a Thrinaxodon fossil. Their models show a membrane in the jaw could work as an eardrum, pushing the origin of sensitive mammal hearing back by nearly 50 million years.
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
Low-cost cooling could help Bangladesh garment workers
A University of Sydney study, published in The Lancet Planetary Health on Monday (20 October), tested simple low-cost cooling in a chamber that mimicked extreme factory heat. Fans and water partly restored productivity; a reflective roof cut indoor temperature by 2.5°C.
Financial worries disrupt sleep in National Guard members
A study of full-time Army and Air National Guard members found that financial stress leads to tense bedtime habits and poorer sleep. Researchers measured stress, bedtime behaviours, and sleep using surveys and wrist actigraphs.